1.
Adervances in the Research of the Resistance Reversal Agent on Multidrug Resistance of Cancer Cell;
肿瘤多药耐药逆转剂及逆转策略研究进展
2.
Establishment of Multidrug-resistant Lung Adenocarcinoma Cell Lines A549/ADM and Reversal of Drug-resistance;
肺腺癌多药耐药细胞系的建立及耐药逆转剂的研究
3.
The Study of a New Oral Preparation of Tumorous Multidrug-Resistance Inhibit Agent-Pyronaridine Phosphate;
肿瘤多药耐药逆转剂—磷酸咯萘啶口服新剂型的研究
4.
The progress of Chinese herbal compound in reversing multidrug resistance of hepatocellular carcinoma
肝癌多药耐药中药逆转剂的研究进展
5.
The Study of Reversal of Multidrug Resistance in Human Renal Cell Carcinoma by Inhibition Agents of Protein Kinase C Alpha;
蛋白激酶C alpha抑制剂逆转肾癌多药耐药的研究
6.
The Research of Mechanisms and Reversal on Multidrug Resistance of the Human Ostoecorma Cell;
人骨肉瘤细胞多药耐药机制及其逆转剂的研究
7.
Research Progress on Multidrug Resistance of Nasopharyngeal Carcinoma By Multidrug Resistance-protein and the Reversal Drugs
耐药蛋白介导的鼻咽癌多药耐药机制及其逆转剂的研究进展
8.
Advance in the research of mechanism of drug resistant protein -mediated multidrug resistant nasopharyngeal carcinoma and its reversam agents
耐药蛋白介导的鼻咽癌多药耐药机制及其逆转剂研究进展
9.
Mechanisms and Reversal of Resistance to Alkylating Agent Melphalan (Mel);
烷化剂马法兰的耐药机制及逆转途径的研究
10.
Rhaponticum Uniflorum (L.) DC. Takes Out Tomention the Dose Tumor Multidrug Resistance Turning and Inducing Apoptosis;
中药RHU抽提剂逆转肿瘤多药耐药及诱导凋亡的实验研究
11.
Reversal of Multidrug Resistance of K562/ADM in Nude Mice of by FuFang TengLiGen Mixture;
复方藤梨根制剂对K562/ADM荷瘤裸鼠体内多药耐药逆转机制研究
12.
Effect of Cyclosporine A and Estrogen-receptor Inhibitor on the Reversion of Multidrug Resistance of K562/A02 Line;
环孢菌素A联合雌激素受体抑制剂逆转K562/A02细胞多药耐药的研究
13.
The HIV-1 Pharmacological Models Which Resist to Non-nucleoside Reverse-transcriptase Inhibitors;
对非核苷类逆转录酶抑制剂耐药型HIV-1药理模型的建立
14.
Experimental Study of Multidrug-resistance Leukemia Mechanism Reversed by Proteasome Inhibitor Bortezomib;
蛋白酶体抑制剂硼替佐米逆转白血病多药耐药机制的实验研究
15.
Clinical study of high-dose toremifene in reversing multidrug resistance and enhancing chemosensitivity of NSCLC
大剂量托瑞米芬逆转肺癌多药耐药及化疗增敏的临床研究
16.
Establishment of pharmacological evaluation system for non-nucleoside reverse-transcriptase inhibitors resistant HIV-1
非核苷类逆转录酶抑制剂耐药型HIV-1药理评价体系的建立
17.
Involved Mechanism of Proteasome Inhibitor Bortezomib-Mediated Acquired TRAIL Resensitization in Human Colon Cancer Cell;
蛋白酶体抑制剂bortezomib逆转结肠癌细胞获得性TRAIL耐药的机制研究
18.
Studies on the Anticancer and Reversing Multidrug Resistance Effects of Abnormal Savda Munziq Total Flavonoids;
异常黑胆质成熟剂总黄酮抗肿瘤及逆转肿瘤细胞耐药性机制研究